Description
DEOB FY20 640C09049.
Base award description: NON-PET RADIOPHARMACEUTICALS
Modification chain · 9 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2017-10-03+$283,042= $283,042
- Mod P000012018-10-01+$283,042= $566,084
- Mod P000022019-10-01+$70,761= $636,845
- Mod P000032019-12-23+$56,521= $693,366
- Mod P000042020-03-20+$56,521= $749,887
- Mod P000052020-07-01+$56,521= $806,408
- Mod P000062020-07-29-$145,850= $660,558
- Mod P000072021-03-02-$91,129= $569,429
- Mod P000082021-05-28-$34,608= $534,821
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2017-10-03 | +$283,042 | $283,042 | NON-PET RADIOPHARMACEUTICALS |
| Mod P00001· EXERCISE AN OPTION | 2018-10-01 | +$283,042 | $566,084 | NON-PET RADIOPHARMACEUTICALS |
| Mod P00002· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2019-10-01 | +$70,761 | $636,845 | NON-PET RADIOPHARMACEUTICALS |
| Mod P00003· EXERCISE AN OPTION | 2019-12-23 | +$56,521 | $693,366 | 3 MONTH EXTENSION |
| Mod P00004· CHANGE ORDER | 2020-03-20 | +$56,521 | $749,887 | 3 MONTH EXTENSION |
| Mod P00005· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-07-01 | +$56,521 | $806,408 | 3 MONTH EXTENSION |
| Mod P00006· FUNDING ONLY ACTION | 2020-07-29 | −$145,850 | $660,558 | 3 MONTH EXTENSION |
| Mod P00007· FUNDING ONLY ACTION | 2021-03-02 | −$91,129 | $569,429 | 3 MONTH EXTENSION |
| Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2021-05-28 | −$34,608 | $534,821 | DEOB FY20 640C09049. |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI CETPVZL5RQS3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926N0409 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C24826N0693 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $111,150 | FY2026 |
| 36C25226N0456 | 252-NETWORK CONTRACT OFFICE 12 (36C252) · 6505 · DRUGS AND BIOLOGICALS | $34,735 | FY2026 |
| 36C26326F0080 | NETWORK CONTRACT OFFICE 23 (36C263) · 6505 · DRUGS AND BIOLOGICALS | $27,788 | FY2026 |
| 36C25726N0272 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $257,789 | FY2026 |
| 36C25726D0056 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under 6505 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C26126P1178 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
| 36C26126P1102 | ENVIGO RMS LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $74,586 | FY2026 |
| 36C26126P0961 | 10X GENOMICS, INC. | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $34,600 | FY2026 |
| 36C26126P0997 | SIERRA RADIOPHARMACY LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $247,204 | FY2026 |
| 36C26126P1008 | OPTUM FRONTIER THERAPIES II, LLC | 261-NETWORK CONTRACT OFFICE 21 (36C261) | $58,374 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26118P0030_3600_-NONE-_-NONE- · retrieved 2026-09-26.